Please login to the form below

Not currently logged in


This page shows the latest Acino news and features for those working in and with pharma, biotech and healthcare.

Oncology bias in pharma deals

Regorafenib is in phase III. 160. Cephalon/Acino. Regional business acquisition. Generics.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch table for October 2013 Deal Watch table for October 2013

    440. Acino / Avista Capital and Nordic Capital. Acquisition. Portfolio of drug delivery products (marketed).

  • Pharma deals during October 2013 Pharma deals during October 2013

    The other major deal featuring PE is the acquisition of Acino by Avista Capital Partners and Nordic Capital for $439m. ... share. The sale has been strongly supported by the Acino Board, notably the stock had fallen by 62 per cent over the last five years

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...